Table 1 Demographics and clinical characteristics of the study population
Finding N= 392 (%)
Demographics, comorbidities Demographics, comorbidities
Age in months, median (IQR) 27 (7, 126)
Sex Sex
Female 183 (47)
Male 209 (53)
Chronic cardiac disease, including congenital heart disease (no hypertension) 0 (0)
Hypertension 1 (0.3)
Asthma (or recurrent wheezing) 47 (12)
Immunosupressors 8 (2.0)
Symptoms and labs Symptoms and labs
Fever days >= 3 224 (57)
Oxygen saturation %, median (IQR) 391 -93.0 (90.0, 96.0)
Cough 264 (67)
Sorethroat 76 (19)
Runny nose 251 (64)
Wheezing 94 (24)
Chest pain 29 (7.4)
Myalgia 44 (11)
Jointpain 30 (7.7)
Fatigue 132 (34)
Dyspnea 162 (41)
C reactive protein mg/L, median (IQR) 7 (2, 34)
Procalcitonin ng/mL, median (IQR) 1 (0, 13)
PCR obtained for 16 viruses in respiratory secretion 59 (15)
Codetection
Yes 52 (13)
No 260 (66)
Unknown due to lack of microbiological data 80 (20)
Codetecion type
Virus-Bacteria 9 (17)
Virus-Virus 43 (83)
Unknown 340
Evolution Evolution
Oxygen therapy 267 (68)
Oxygen therapy time in days, median (IQR) 4 (3, 7)
High-flow therapy 56 (14)
High-flow therapy time in days, median (IQR) 4 (2, 6)
PICU admission 89 (23)
PICU time in days, median (IQR) 5 (3, 8)
Mechanical ventilation 27 (30)
Non-invasive mechanical ventilation 5 (19)
Invasive mechanical ventilation 23 (85)
Complications 53 (14)
Pleural effusion 14 (26)
Effusion type
Complicated (pH< 7 and/or partitions) 2 (14)
Not complicated 12 (86)
Pneumatocele abscess 1 (1.9)
Pneumothorax 3 (5.7)
Sepsis 20 (38)
Death 11 (2.8)